COVID-19 Lung Injury: Unique and Familiar Aspects of Pathophysiology
Open Access
- 27 November 2024
- journal article
- review article
- Published by MDPI AG in Applied Sciences
- Vol. 14 (23) , 11048
Abstract
Acute lung injury (ALI), diagnosed clinically as acute respiratory distress syndrome (ARDS), refers to a spectrum of acute inflammatory processes culminating in increased permeability of the pulmonary alveolar–capillary barrier and impaired gas exchange. The pandemic caused by the novel coronavirus, SARS-CoV-2, has raised questions as to the similarities and differences between COVID-19 lung injury and ALI of other etiologies. This review summarizes current knowledge regarding the pathophysiology of ALI and COVID-19 lung injury and draws comparisons between the latter and other infectious etiologies of ALI. Indeed, severe COVID-19 is characterized by a unique array of disease mechanisms including suppression of interferon responses, widespread inflammasome activation, altered leukocyte phenotypes, and hyperactive thrombotic activity. Moreover, these mechanisms manifest as a unique clinical progression, which further differentiates COVID-19 from other viral respiratory pathogens such as SARS, MERS, and influenza. These unique features of COVID-19 pathophysiology bear important implications for current and future therapeutic strategies.Keywords
This publication has 205 references indexed in Scilit:
- Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19JAMA, 2022
- COVID‐19‐related coagulopathy: A review of pathophysiology and pharmaceutical managementCell Biology International, 2021
- COVID‐19: immunopathology, pathophysiological mechanisms, and treatment optionsThe Journal of Pathology, 2021
- ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID‐19Journal of Cellular Physiology, 2020
- From virus to inflammation, how influenza promotes lung damageJournal of Leukocyte Biology, 2020
- Epidemiology of COVID‐19: A systematic review and meta‐analysis of clinical characteristics, risk factors, and outcomesJournal of Medical Virology, 2020
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, ChinaJAMA Internal Medicine, 2020
- Neutrophils in the initiation and resolution of acute pulmonary inflammation: understanding biological function and therapeutic potentialThe Journal of Pathology, 2018
- Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 CountriesJAMA, 2016
- Acute Respiratory Distress SyndromeJAMA, 2012